BBSRC Portfolio Analyser
Award details
PhD studentship: Role of PI3K in autoimmunity and infection
Reference
BBS/E/B/0000H260
Principal Investigator / Supervisor
Professor Klaus Okkenhaug
Co-Investigators /
Co-Supervisors
Institution
Babraham Institute
Department
Babraham Institute Department
Funding type
Research
Value (£)
26,682
Status
Completed
Type
Institute Project
Start date
08/08/2010
End date
07/08/2014
Duration
48 months
Abstract
Autoimmune diseases such as Rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis can be caused by the immune system which instead of fighting pathogens, turns on different organs in the body. The aim of this project is to determine if inhibition of an enzyme called PI3K p110delta can be used to alleviate autoimmunity. At the same time, we will determine if inhibition of p110delta increases risk of infection with common bacteria. These studies will help determine whether p110delta is a good drug target.
Summary
unavailable
Committee
Not funded via Committee
Research Topics
Immunology, Pharmaceuticals
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search